Depression Clinical Trials in Austin, TX

Depression Clinical Trials in Austin, TX

View the best 10 depression medical studies in Austin, Texas. Access promising new therapies by applying to a Austin-based Depression clinical trial.

Trials in Austin, Texas

Here are the top 9 medical studies for depression in Austin, Texas

Image of Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600 in Austin, United States.

Sertraline

Selective Serotonin Reuptake Inhibitor

Recruiting3 awardsPhase 4
This trial aims to use brain scans to predict how well patients with major depression will respond to the antidepressant sertraline. Sertraline, one of the oldest antidepressants, remains the most effective treatment for depression. By identifying specific brain activity patterns, doctors hope to better tailor treatments for each patient, improving outcomes for those who may not respond to typical treatments.
Image of Collaborative Neuroscience Research, LLC in Torrance, United States.

SEP-4199 CR 200 mg +1 More

Verified
Recruiting1 awardPhase 3
This trial is testing a new medication called SEP-4199 CR to see if it can help adults aged 18-65 who have depression from Bipolar I disorder. The study will compare the effects of the medication to see if it reduces symptoms of depression. SEP-4199 has shown antidepressant efficacy in a previous study for bipolar depression.
Image of Emory University Hospital in Atlanta, United States.

Lifestyle Physical Activity Promotion Program

Behavioral Intervention

Recruiting1 award2 criteria
This trial is testing the effectiveness of a Web App-based lifestyle physical activity promotion program on depressive symptoms in midlife Korean American women.
Image of Advanced Research Center /ID# 227073 in Anaheim, United States.

Cariprazine +1 More

Atypical Antipsychotic

Recruiting1 awardPhase 3
This trial is testing the safety and effectiveness of Cariprazine for treating depressive episodes in children and teenagers with bipolar I disorder. The goal is to find out if Cariprazine can help young people with this condition. Cariprazine is an atypical antipsychotic recently approved for the treatment of depressive episodes in adults with bipolar I disorder.
Image of Site 187 Yuma CNS Research in Yuma, United States.

ALTO-300

Verified
Recruiting0 awardsPhase 2
This trial is testing ALTO-300, a new medication, to see if it can make antidepressants work better for patients who are already taking them.
Image of Clinical Site 105 in Lauderhill, United States.

CLE-100

Recruiting0 awardsPhase 2
This trial tests a new medication in people with major depression who haven't improved with at least two other treatments. The drug works by changing brain chemicals to improve mood quickly. It has been approved for adults with difficult-to-treat depression and has been tested in various forms.
Image of Clinical Research Site in Bellflower, United States.

AXS-05

Behavioural Intervention

Recruiting3 awardsPhase 4
This trial is testing AXS-05, a new medication, to see if it can prevent depression from returning in people who have already improved with it. The study focuses on those with major depressive disorder and aims to maintain their balanced brain chemicals to keep them feeling better. AXS-05 (a combination of dextromethorphan and bupropion) has shown positive results in previous trials for major depressive disorder.
Image of Mountain View Clinical Research in Denver, United States.

Psilocybin

Psychedelic Therapy

Recruiting1 awardPhase 3
This trial is testing psilocybin, a substance from mushrooms, to see if it can help adults with depression who may not respond well to current treatments. Psilocybin works by affecting brain chemicals related to mood. Psilocybin has shown promise as a treatment for major depressive disorder and was designated as a breakthrough therapy by the FDA in 2019.
Image of MacArthur Clinic in Waco, United States.

Brief Unified Protocol

Behavioral Intervention

Recruiting1 award1 criteria
This trial aims to see if a workshop on emotion regulation training delivered by peers can help prevent posttraumatic stress and other mental health symptoms in firefighter trainees. They will compare those who receive this training

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.